Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume.

Source:http://linkedlifedata.com/resource/pubmed/id/18583890

Download in:

View as

General Info

PMID
18583890